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Polyadenylation of messenger RNA precursors re- 
quires  the  nucleotide  sequence AAUAAA  and two fac- 
tors:  poly(A)  polymerase  and  a specificity factor 
termed  cleavage  and  polyadenylation  factor (CPF). We 
have  purified CPF from calf  thymus  and  from  HeLa 
cells to  near  homogeneity.  Four  polypeptides with mo- 
lecular  masses of 160,100,73, and 30 kDa  cofraction- 
ate with CPF activity. Glycerol gradient centrifuga- 
tion and gel filtration  indicate  that  these  four  proteins 
form  one  large  complex with a sedimeptation  constant 
of 12 S, a Stokes radius near 100 A, and a native 
molecular mass near 500 kDa. Purified CPF binds 
specifically to an RNA that contains the AAUAAA 
sequence.  Mutation  of  the AAUAAA sequence  inhibits 
CPF binding as well as polyadenylation.  Purified CPF 
contains  only  trace  amounts  of RNA and  does  not  react 
with antibodies  against common epitopes  of  small  nu- 
clear ribonucleoprotein particles. Thus, contrary to 
previous  indications, CPF does  not  appear  to  be  a  small 
nuclear  ribonucleoprotein  particle. 
The 3‘ ends of eukaryotic messenger RNAs are formed by 
endonucleolytic cleavage of the primary  transcript  and  the 
subsequent addition of approximately 200 adenosine residues 
to  the upstream cleavage product. Two cis-acting sequence 
elements confer specificity to  the 3”processing reaction; 10- 
30 nucleotides upstream of the polyadenylation site lies the 
highly conserved sequence AAUAAA. Less conserved GU- or 
U-rich sequence elements are located downstream (for re- 
views, see Birnstiel et al. (1985), Manley (1988), Wickens 
(1990), and Proudfoot (1991). Single base substitptions or 
modifications in  the AAUAAA sequence inhibit or completely 
abolish cleavage as well as polyadenylation. The incorporation 
of substrate RNA into  the so-called 3‘-processing complex is 
also strongly dependent on the  intact AAUAAA motif (Hum- 
phrey et al. 1987;  Zarkower and Wickens, 1987a,  1987b; Skol- 
nik-David et al., 1987; Zhang and Cole, 1987; Moore et al., 
1988; Stefano and Adams, 1988). Cleavage and polyadenyl- 
ation  are normally tightly coupled in vivo and in  vitro. How- 
ever, cleaved  RNA lacking poly(A) tails accumulates in  vitro 
in  the presence of EDTA or  a  chain-terminating ATP ana- 
logue (Moore and  Sharp, 1985). Polyadenylation can be ex- 
amined independently of cleavage  by use of a  synthetic RNA 
substrate that terminates at or close to  the  natural cleavage 
and polyadenylation site. 
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At least four factors  are involved in the complete 3“proc- 
essing reaction. One factor that has been purified to  apparent 
homogeneity and characterized in detail is poly(A) polymerase 
(Wahle, 1991), a  protein of 60 kDa that nonspecifically poly- 
adenylates  any RNA in  the presence of manganese ions. In 
the presence of magnesium ions, the polymerase is barely 
active. Under these conditions, another factor, cleavage and 
polyadenylation factor (CPF),’ endows the poly(A) polymer- 
ase with activity specific for AAUAAA-containing RNAs 
(Christofori and Keller, 1988, 1989; Takagaki et al., 1988, 
1989; McDevitt et al., 1988; Wahle, 1991). CPF, which has 
also been called specificity factor  (SF;  Takagaki et al. (1989)) 
or polyadenylation factor 2 (PF2;  Gilmartin  and Nevins 
(1989)), directly interacts with the AAUAAA sequence (Gil- 
martin and Nevins, 1989; Bardwell et al. 1991).’ Poly(A) 
polymerase and  CPF  are sufficient to polyadenylate an RNA 
substrate  that includes the AAUAAA sequence close to  its 3’ 
end. 
In addition to these two components, at least two more 
factors  participate  in the cleavage reaction (Christofori and 
Keller, 1988; Gilmartin et al., 1988; Gilmartin and Nevins, 
1989; Takagaki et al., 1989; Takagaki et al., 1990). 
A U-type small nuclear ribonucleoprotein particle (U- 
snRNP) has been suspected to be  involved in the 3”process- 
ing reaction since other RNA-processing reactions such as 
RNA splicing and histone 3’ end processing require the activ- 
ity of different snRNPs (Lamond et al., 1990; Birnstiel  and 
Schaufele, 1988). In agreement with this expectation, anti- 
Sm antibodies directed against  a common epitope of all U- 
type snRNPs have been shown to inhibit the 3’-processing 
reaction (Moore and Sharp, 1984; Berget and Robberson, 
1986). In addition, an RNA fragment that contained the 
AAUAAA sequence was immunoprecipitated from processing 
reactions by snRNP-specific antibodies  (Hashimoto  and 
Steitz, 1986; Stefano  and Adams, 1988). Furthermore, it has 
been reported that a 155-kDa protein that could  be specifically 
cross-linked to  the AAUAAA sequence could be immunopre- 
cipitated with the same antibodies (Moore et al., 1988). During 
the fractionation of 3’-processing factors, a copurification of 
the U11 snRNP (Kramer, 1987) with CPF activity was ob- 
served (Christofori and Keller, 1988). However, no direct 
proof for the involvement of the U11 snRNP in the 3‘- 
processing reaction was found. 
Here, we report the purification of CPF  to near homoge- 
neity from calf thymus  and from HeLa cell nuclear extract. 
CPF was found to be a complex of four polypeptides, and  it 
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contained only trace amounts of U11 RNA. Proteins common 
to all U snRNPs were not detectable. 
EXPERIMENTAL PROCEDURES 
Materials-Poly(A) polymerase was purified as described (Wahle, 
1991). SP6 RNA polymerase, T7 RNA polymerase, and proteinase  K 
were from Boehringer Mannheim. RNAguard was from Pharmacia 
LKB Biotechnology Inc., bovine serum albumin (RNase-free)  from 
Biofinex (CH-1724 Praroman),  and bovine serum albumin (fraction 
V) from Boehringer Mannheim. Monoclonal antibodies directed 
against the common 2,2,7-trimethylguanosine cap structure of sn- 
RNPs and coupled to Sepharose 4B (anti-m& affinity column) 
(Bochnig et al., 1987) were a gift from R. Luhrmann, University of 
Marburg, FRG. Spermine agarose was from Sigma. Blue Sepharose 
was made from Sepharose CL-GB (Pharmacia) and reactive blue 
(Basilen Blue E-3G, Sigma no. B-5520) according to Bohme et al. 
(1972). 1 g of reactive blue was used for 100 ml (packed volume) of 
Sepharose CL-GB. All other resins were from Pharmacia. Polyvinyl 
alcohol (molecular mass, 40 kDa), polyvinylpyrrolidone (molecular 
mass, 40 kDa), and herring sperm DNA (type  XIV) were from Sigma, 
ammonium sulfate from Bethesda Research Laboratories, Nonidet 
P-40 from Fluka, dithiothreitol from Calbiochem, dextran  sulfate and 
Ficoll-400 from Pharmacia, phenylmethylsulfonyl fluoride from 
Boehringer Mannheim, and leupeptin and pepstatin from Bachem 
AG (CH-4416 Bubendorf). Labeled nucleoside triphosphates were 
from Amersham Corp., and nonlabeled nucleoside triphosphates were 
from Pharmacia. 
In Vitro Synthesis of Pre-mRNA-The RNAs used as substrates 
for the specific polyadenylation reaction contained the adenovirus-2 
L3 polyadenylation site. The precleaved substrates (LBpre, L3preA), 
terminating one nucleotide upstream of the  natural polyadenylation 
site, have been described (Christofori and Keller, 1988). L3pre con- 
tained an  intact AAUAAA recognition signal, whereas L3preA has  a 
U to G point  mutation  in this sequence. The in vitro transcription by 
SP6 RNA polymerase from a truncated plasmid DNA included the 
addition of a GpppG cap to  the RNA and  the incorporation of [a- 
"PIUTP (Frendewey and Keller, 1985; Kramer and Keller, 1985). 
The  UTP concentration was 0.1 mM. 
Unlabeled competitor RNA was synthesized essentially as de- 
scribed above with the following modifications. The reaction volume 
was increased to 100 pl, and incubation was performed for 90 min. 
The concentration of template DNA was 0.02 pg/pl, the  UTP con- 
centration was 0.5 mM, and  [a-32P]UTP was omitted from the reac- 
tion. After purification by electrophoresis on  a 6% denaturing poly- 
acrylamide gel, the RNA  was visualized by  UV shadowing (254 nm), 
excised from the gel, and eluted overnight at 37 "C in 0.75 M ammo- 
v) SDS, and 0.1 mM EDTA. The eluted RNA was purified by extrac- 
nium acetate,  10 mM magnesium acetate, 1% (v/v) phenol, 0.1% (w/ 
tion with phenol and ch1oroform:isoamyl alcohol (241)  and ethanol- 
precipitated. The RNA pellet was resuspended in 300 ~l of HzO and 
quantified spectrophotometrically. 
In Vitro Synthesis of U11 Sense and Antisense RNA-Synthetic 
U11 RNA  was derived from phage M13 mp18 DNA that contained, 
cloned in its HindIII  site,  a fragment with the  T7 promoter upstream 
of the human U11 snRNA gene (CS 23) (Suter-Crazzolara and Keller, 
1991). For run-off transcription, the vector was linearized with DraI. 
The transcript contained all 134 nucleotides of U11 RNA and 3 
guanosine residues at its 5' end (Montzka and Steitz, 1988, Suter- 
Crazzolara and Keller, 1991). Unlabeled RNA was synthesized in  a 
total volume of 100 pl, containing 40 mM Tris-HC1, pH 8.0, 8 mM 
MgCIz, 2 mM spermidine, 50 mM NaCl, 10 mM dithiothreitol, 0.5 mM 
each of ATP, GTP,  CTP,  and  UTP, 2 pg  of template DNA, 120 units 
of RNAguard, and 20 units of T7 RNA polymerase. After incubation 
for 60 min at  37 "C, the  transcripts were purified as described above. 
Radiolabeled U11 antisense RNA was synthesized by T7 RNA 
polymerase from a Bluescript KS+ vector that contained the human 
U11 gene in an inverted orientation downstream of the  T7 promoter 
(Fis I) and which  was linearized with PstI. FisI was made by cloning 
a Sad-Hind111 fragment containing the U11 sequence into SacI- and 
HindIII-cut Bluescript KS+. The  transcript contained, at  its 5' end, 
11 nucleotides of Bluescript sequence followed  by  25 nucleotides of 
M13 mp18 sequence and 127 nucleotides of sequence complementary 
to U11  RNA and, at  its 3' end, 5 nucleotides of M13 mp18 sequence. 
Transcriptions were performed in 20 pl containing 40 mM Tris-HCI, 
pH 8.0, 8 mM MgCl2, 2 mM spermidine, 50 mM NaC1, 10 mM 
dithiothreitol, 0.5 mM each of ATP, CTP,  and  GTP, 0.02 mM UTP, 
50 +Ci of [a-3ZP]UTP (800 Ci/mmol), 30 units of RNAguard, 10 units 
of T7 RNA polymerase, and 1 pg of template DNA for 30 min at 
37  "C. The RNA  was purified as described (Frendewey and Keller, 
1985). 
Specific Polyadenylation-The polyadenylation reaction was as 
described (Christofori and Keller, 1988), with the following modifi- 
cations. 0.01% Nonidet P-40 and 0.2 mg/ml RNase-free bovine serum 
albumin were included. 60 fmol of RNA (1-5 X 10' cpm) and 8-10 
units of purified poly(A) polymerase were used per reaction. All 
reactions were incubated for 30 min at 30 "C and stopped by the 
addition of proteinase  K mix (20 pg  of proteinase K and 5 pg  of tRNA 
in 180 pl of 100 mM Tris-HC1, pH 7.5,  20 mM EDTA, 2% N- 
lauroylsarcosine) and incubation for 30 min at 30  "C. The RNA was 
precipitated by the addition of 100 p1 of 7.5 M ammonium acetate 
and 750 p1 of ethanol. After one wash with 70% ethanol, the RNA 
was analyzed on  a 12% denaturing polyacrylamide gel (Sambrook et 
al., 1989). 
For quantitation of CPF activity, elongated and nonelongated 
substrate RNA was excised from the gel. Gel  pieces  were placed in a 
scintillation mixture (Instagel, Packard Instrument Co.) and counted 
in a scintillation  counter. One unit of CPF is defined as  the amount 
that leads to  the polyadenylation of 50% of the substrate RNA. 
Gel Retardation Assay-The standard reaction used for the gel 
retardation assay was essentially the same as  the 3'-processing reac- 
tion, with the following modifications. Substrate RNA  was increased 
to 100 fmol (2-8 X lo4 cpm)  per reaction and  the  ATP concentration 
was raised to 1.6 mM. After 10 min at  30 "C, the reaction mixtures 
were loaded directly onto a 4% nondenaturing polyacrylamide gel 
(Frendewey et al., 1987). Bromphenol blue and xylene cyanol were 
applied to neighboring lanes, and electrophoresis was carried out at 
room temperature a t  20 mA until the xylene cyanol had migrated 
10.5  cm into  the gel. Complexes were visualized by autoradiography. 
Purification of Cleavage and Polyadenylation Factor from Calf Thy- 
mus-Buffer A contained 10% (v/v) glycerol, 3 mM MgC12, 50 mM 
Tris-HC1, pH 7.0,0.2 mM EDTA, 0.5 mM dithiothreitol. Buffer B was 
the same as buffer A but contained 20%  glycerol. The  pH of the  Tris 
buffer was adjusted as a 1 M stock solution at room temperature. Salt 
concentrations were as indicated. All columns were run at or close to 
0 "C and 1 column volume/h, unless indicated otherwise. Protein 
concentrations were determined according to Bradford (1976) with 
BSA (fraction V) as a  standard. 
Extract was prepared from 1 kg of calf thymus as described (Wahle, 
1991), except that  the tissue was homogenized in buffer A  containing 
100 mM KC1 and 1 mM EDTA. 
The crude  extract was applied to a DEAE-Sepharose column of 45 
X 10 cm, equilibrated in buffer A plus 100 mM KCl, with 10 mg of 
protein loaded per ml of bed volume. The column was washed with 1 
volume of buffer A  containing 100 mM KC1 and eluted with a gradient 
(3 column volumes) from 100 to 300 mM KCl. CPF activity eluted 
from 175 to 250 mM KC1. The pooled fractions were adjusted to 45% 
saturation with solid ammonium sulfate and stirred overnight on ice. 
After centrifugation (60 min, 8000 rpm (10,800 X gm.J Sorvall GS3 
rotor), the pellet was resuspended in 80 ml of buffer A, dialyzed for 8 
h  against  4 X 2 liters  or overnight against 10 liter of buffer A plus 
100 mM KCl, and clarified by centrifugation for 15 min at 15,000 rpm 
(27,000 X gmax) in  a Sorvall SS34 rotor. The fraction was diluted to 
the conductivity of buffer A  containing 100 mM KC1. 
A blue Sepharose column (20 X 10 cm)  was equilibrated with buffer 
A  containing 100 mM KCl. The dialyzed precipitate was applied with 
with 1 volume of buffer A plus 100 mM KC1 and developed with a 
2 mg  of protein/ml of column bed  volume. The column was washed 
gradient from 0.1 to 1 M KC1 in buffer A ( 5  column volumes). The 
active fractions  (eluted at 600-900 mM KCI)  were pooled and dialyzed 
for 6  h  against  3 X 2 liters of buffer B and  then for 2  h against 6 liters 
of buffer B plus 100 mM KCl. 
The blue Sepharose pool was applied to a heparin-Sepharose 
column (15 X 3.5 cm) equilibrated with buffer B plus 100 mM KCl. 
Loading was done overnight with 2 mg  of protein/ml of column bed 
volume and followed by washing with 2 column volumes of buffer B 
plus 100 mM KCl. CPF was eluted with a 5-column volume gradient 
from 100 to 300 mM KC1 and was recovered between 180 and 240 mM 
KC1. After dialysis (6  h  against  3 X 2 liters of buffer A plus 100 mM 
KCl) the solution was centrifuged for 30 min at 12,000 rpm (23,400 
X gmaJ in  a GSA rotor. 
An 8-ml Mono Q FPLC column was equilibrated with buffer A 
plus 100 mM KC1, and  the heparin-Sepharose pool  was loaded. After 
washing with 2 column volumes, the protein was eluted with a 40- 
column volume gradient from 100 to 500 mM KC1 in buffer A at 2 
ml/min. To  the pooled fractions (eluted at 270-300 mM KCl), Nonidet 
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P-40 was added to a final concentration of 0.02%. The inclusion of 
Nonidet P-40 in this  and all following buffers resulted in increased 
stability  and recovery of CPF activity. The Mono Q pool  was dialyzed 
for 6 h against 3 X 1 liter of buffer B  containing 100 mM KC1. 
buffer B plus 100 mM KCI, lacking EDTA. After loading (1 mg of 
A spermine-agarose column (13 X 1 cm) was equilibrated with 
protein/ml of column bed volume) the column was washed with 2 
column volumes of the same buffer and developed with a gradient (8 
column volumes) from 100 to 320 mM KC1 in buffer B  minus EDTA 
and finally washed with 1 column volume of 320 mM  KC1. CPF 
activity was found between 220 and 300 mM KCI,  pooled, and dialyzed 
against buffer B  containing 50 mM KC1 (4.5 h,  3 X 0.5 liter). 
A poly(A)-Sepharose column (13 X 1 cm) was equilibrated with 
buffer B plus 50 mM KCl. The spermine-agarose pool  was applied to 
the column with 0.25  mg  of protein/ml of column bed  volume, and 
the column was washed with 1 column volume of buffer B plus 50 
mM KC1 and 2 column volumes of buffer B plus 100 mM KCI. CPF 
was eluted with a 1 M KC1 step in buffer B. 
More recently, we have omitted the spermine-agarose column and 
eluted the poly(A)-Sepharose column with a 0.5 M KC1 step. The 
yield with this purification was 2-fold higher, and  the purity was as 
high as that of the preparation described in detail above. 
Purification of CPF from HeLa Cells-Nuclear extracts from 500 g 
of HeLa cells were prepared according to Dignam et al.  (1983). The 
same purification steps as described above  were performed with the 
following modifications. The DEAE-Sepharose pool was loaded di- 
rectly onto a blue-Sepharose column without prior ammonium sulfate 
precipitation. The heparin-Sepharose fraction was applied to a 1-ml 
Mono Q FPLC column. Finally, the spermine-agarose column was 
omitted and  the Mono Q pool  was directly applied to  the poly(A)- 
Sepharose column. During all  fractionation steps, HeLa CPF behaved 
comparable with calf thymus CPF. 
Glycerol Gradient Centrifugation-1  ml of a poly(A)-Sepharose pool 
of  calf thymus CPF was dialyzed for 4  h against 2 X 0.5 liter of buffer 
A plus 100 mM KC1, and 300  pl of the dialysate was layered on  top of 
a 15-40%  glycerol gradient (13 ml, 14 X 95-mm tubes)  in 50 mM Tris- 
HC1, pH 7.0, 100 mM KCI, 3 mM MgCl,, 0.2 mM EDTA, 0.5 mM 
dithiothreitol. Sedimentation was performed for 34 h at  4 "C and 
39,000 rpm (273,000 X g,,,) in a Kontron TST 41.14 rotor. The 
gradient was unloaded from the top  in 300-p1 fractions (40 fractions/ 
tube), and  CPF was identified by its activity. 
CsCl Buoyant Density Centrifugation-4 ml  of a calf thymus CPF 
Mono Q pool  (0.4  mg/ml protein)  in buffer A plus 100 mM KC1 were 
adjusted to a final density of  1.45 g/cm3 with solid CsC1. Centrifuga- 
tion was performed for 43 h at  4 "C at  52,000 rpm (200,000 X gmJ in 
a Kontron TFT 80.4 rotor. 150-pl fractions were collected from the 
top of the gradient and dialyzed overnight in  a microdialysis system 
(Bethesda Research Laboratories) against buffer B plus 100 mM KCl. 
In the same run, CsCl gradients were formed with bovine serum 
albumin (0.5 mg/ml) or a Mono Q fraction containing a random 
assortment of protein (0.3 mg/ml) but no snRNPs. Proteins were 
quantified by their UV absorbance. 
Affinity Chromatography of CPF on an Anti-m3G Column-Par- 
tially purified CPF was applied to  an affinity column that carried 
monoclonal antibodies against the trimethylguanosine cap structure 
of snRNPs (see above). A 100-p1 affinity column was made in  a 200- 
pl pipette tip and equilibrated with TMN 300 (20 mM Tris,  pH 7.9, 
10 mM MgCl,,  300 mM NH4C1,  0.5 mM dithiothreitol, 10% glycerol). 
20 pl  (1600 units) of a  concentrated spermine-agarose fraction (con- 
centrated 20-fold on a  1-ml Mono Q column) was applied. The column 
was washed with 100 p1 of TMN 300, and the flow-through was 
with 500 p1 of TMN 300. Bound material was eluted with 500 p l  of 
reloaded several times for 1 h,  total. Unbound material was eluted 
TMN 100 (as  TMN 300 but 100 mM NH4Cl), including 10 mM 7- 
methylguanosine (Bochnig et al., 1987). 
Northern Blotting-20 X SSC and 50 X Denhardt's solution were 
according to Sambrook et al. (1989). Blotting buffer consisted of 100 
mM Tris acetate, 50 mM sodium acetate,  5 mM EDTA, pH 7.8, and 
hybridization buffer was 50% formamide, 5 X SSC, 5 X Denhardt's 
solution, 1% SDS, 2.5% dextran sulfate, 50 mM sodium phosphate, 
pH 6.5, 0.1 mg/ml herring sperm DNA. 
For quantitation of U11  RNA in various CPF fractions, appropriate 
amounts of each fraction were treated with proteinase K, ethanol- 
precipitated as described above, and applied to  an 8% polyacrylamide- 
urea gel (Sambrook et al., 1989). As a  standard, known quantities (1- 
20 fmol) of in vitro synthesized U11 RNA were also applied. After 
the run,  the gel  was soaked for 2 X 15 min in  blotting buffer, and  the 
RNA was transferred to a Genescreen membrane (Du Pont-New 
England Nuclear) for 1 h at 150 mA in a semidry blotting apparatus 
in  blotting buffer. The membrane was UV-irradiated for 75 s with 
2000 microwatts/cm' and baked for 1 h at 80 "C. After 2 h of 
prehybridization at 42 "C in hybridization buffer, U11 antisense RNA 
(3-5 X lo5 cpm/ml of hybridization buffer) was added, and hybridi- 
zation was  allowed for 16 h at 42 "C. Washing was performed for  2 X 
30 min in 1 X SSC, 0.1% SDS  and for 2 X 30  min in 0.5 X SSC and 
0.1% SDS at room temperature. After exposure to film, radioactive 
bands were excised from the membrane and counted in a scintillation 
counter. The amount of U11 in CPF fractions was determined by 
comparison to the calibration curve generated with synthetic U11 
RNA. 
SDS-Polyacrylamide Gel Electrophoresis-Appropriate amounts of 
CPF fractions were precipitated by the addition of 1 volume  of 50% 
trichloroacetic acid. After 30 min on ice and 20 min of centrifugation 
(4 "C,  12,000 rpm, 48,000 X g,,,& the pellets were washed two times 
with acetone (cooled to -20 "C), dried, and resuspended in loading 
buffer (3%  SDS (w/v), 10% glycerol (v/v), 63 mM Tris-HC1, pH 6.8, 
and 5% 2-mercaptoethanol (v/v)). The samples were heated for 10 
min at 90  "C and separated on a 9% SDS-polyacrylamide gel accord- 
ing to Laemmli (1970). The gels  were stained with either Coomassie 
Brilliant Blue or with silver. 
RESULTS 
Purification of CPF  from Calf Thymm-CPF was purified 
from extracts of calf thymus. The factor was assayed by its 
ability to complement purified poly(A) polymerase in the 
polyadenylation of radiolabeled substrate RNA that contained 
the adenovirus L3 polyadenylation site. The reaction, which 
was dependent on the AAUAAA signal (see above), was ana- 
lyzed  by gel electrophoresis. For quantitation of CPF activity, 
elongated and nonelongated RNA  was cut from the gel and 
counted in a scintillation counter. CPF activity could be 
observed in the crude calf thymus  extract  but could not be 
quantitated due to  the high nuclease content.  In the first two 
purification steps, the  quantitation of CPF activity was there- 
fore unreliable. 
Purification of CPF was about 500-fold with a yield of 6% 
relative to  the DEAE pool (Table I). We estimate that  the 
total purification was at least 2000-fold. In the last two 
purification steps, the addition of 0.02% Nonidet P-40  stabi- 
lized CPF activity. In a preparation that was performed 
without Nonidet P-40, the recovery of activity was 10 times 
lower. 
On the spermine-agarose column, four polypeptides with 
molecular weights of 160,000,100,000,73,000, and 30,000  were 
the predominant protein species and co-fractionated with 
CPF activity (Fig. 1). Quantitation by scanning densitometry 
showed that  the amount of the four polypeptides relative to 
each other remained constant  through  the peak fractions. The 
pooled spermine agarose fractions were applied to a poly(A)- 
Sepharose column. In this purification step, the  set of the 
four proteins again copurified with CPF activity in a salt 
gradient, whereas most of the remaining polypeptides did not 
bind to  the column (data  not shown). A better recovery of 
CPF was obtained with a single high salt elution step. Fig. 2 
shows the proteins  present  in the pooled poly(A)-Sepharose 
eluate (lane 3 ) .  In addition to some minor contaminants, the 
160-, loo-, 73-, and 30-kDa polypeptides were present in molar 
ratios of  1:1.3:1.5:1.6, as  determined by scanning of the stained 
SDS gel. Since the staining  intensity with Coomassie Brilliant 
Blue varies for different proteins,  this result is not  inconsist- 
ent with an equimolar ratio of all four polypeptides. 
Another preparation of CPF was carried out in the absence 
of Mg2+ and in the presence of the protease inhibitors EDTA 
(1 mM), phenylmethylsulfonyl fluoride (0.5 mM), leupeptin 
(0.4 pg/ml), and  pepstatin (0.7 pg/ml). This purification re- 
sulted in essentially the same ratio of the four polypeptides 
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TABLE I 
Purification of CPFfrom calf thymus 
The purification from 1 kg of calf thymus was carried  out as described under  “Experimental  Procedures.” CPF 
activity could be observed but  not  quantitated  in  the  crude  extract.  The  purification  factor  and recovery are relative 
to  the  DEAE pool. Protein  concentrations were determined  according to Bradford (1976) with BSA as a standard; 
only the  protein  concentration in the  poly(A)-Sepharose pool was estimated by comparison with RSA standards 
on  the  same polyacrylamide gel. 
Fraction Protein Activity Specific activity Purification Recovery 
w units X IO-’ units X lO-“/mg -fold 76 
Extract 37,000 
DEAE-Sepharose 4,300 1,230 0.29 1.0 100.0 
AmSOJ precipitate 1,950 1,200 0.62 2.1 97.6 
Blue-Sepharose 231  575 2.5 8.6  46.7 
Heparin-Sepharose 25  350  14.0  48.3  28.5 
Mono Q 10 280  28.0 96.6  22.8 
Spermine-agarose 2.6 104 40.0 138.0 8.5 
Poly(A)-Sepharose -0.5 74 -148  -510  6.0 
A IP 35 37 39 41 43 45 47 49 51 53  5 57 59 61 
205- 
M IP FT 35 37 39 41 43 45 47  49 51  53 55 57 59 61 M 
205- -205 
116- 
97.4- 
-1 16 
66- 
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29- -29 
FIG. 1. Chromatography of CPF on spermine-agarose. A, A 
Mono Q pool of calf thymus  CPF was run  on  spermine-agarose,  as 
described under  “Experimental Procedures.” CPF activity was meas- 
ured with 0.5 p1 of each  fraction  in a 12.5 pl reaction  (see  “Experi- 
mental  Procedures”).  Fraction  numbers  are  indicated at   the  top. R, 
SDS-polyacrylamide gel electrophoresis of spermine-agarose frac- 
tions, 2 0 4  aliquots of the  fractions  indicated were analyzed  on  two 
9% gels and visualized by staining with Coomassie Brilliant Blue. 
The molecular masses of marker  proteins  in  kilodaltons  are  indicated 
on  the [eft. M, marker  proteins; IP, input; FT, flow-through. 
to each other. In addition, a protein of 140 kDa copurified 
with  CPF (see below). 
Purification of CPF from HeLa Cell Nuclear Extract-CPF 
was also purified from HeLa cell nuclear extract with the 
same assay and  essentially  the  same  purification  steps  that 
were used to purify the  factor  from calf thymus. After five 
steps,  CPF was  purified about 540-fold with a yield of 1.9% 
relative to  the  nuclear  extract  (Table 11). The specific activity 
was similar to that of calf thymus CPF. Fig. 2 shows the 
proteins  present  in  the  poly(A)-Sepharose pool (lane 2). The 
four polypeptides of 160, 100, 73, and 30 kDa again eluted 
116- 
97.4- ‘1 00 
v3 
66- 
29- -30 
1 2 3  
FIG. 2. SDS-gel electrophoresis of calf thymus (CT) and 
HeLa cell CPF. Aliquots of the poly(A)-Sepharose pools of calf 
thymus  CPF  (lane 3;  see  Table I)  and  HeLa cell CPF  (lane 2; Table 
11) were analyzed on a 9% polyacrylamide gel as described under 
“Experimental Procedures.” The same  protein  pattern was observed 
when  the  samples were applied to SDS-gel electrophoresis without 
prior  precipitation  with  trichloroacetic acid and  heat  treatment.  The 
four  predominant polypeptides in these purified fractions are indi- 
cated on the right of the figure. The molecular mass of marker 
proteins  in  kilodaltons  is indicated on  the left of the figure. The gel 
was stained with  Coomassie Brilliant Blue and  the  concentrations of 
the  four polypeptides  were estimated by densitometry of the gel and 
comparison with BSA standards run on the same gel. M ,  marker 
proteins. 
with  CPF  activity  in relative  molar concentrations of 
1:1.1:1.9:1.7. An additional  protein with  a  molecular weight of 
65,000 was present  in  this  fraction. Obviously, this protein 
was present  in  much larger quantities  than  any of the four 
CPF subunits. We assume that the 65-kDa protein was a 
contamination  that was not removed due  to  the omission of 
two purification steps in the CPF preparation from HeLa 
cells (see  “Experimental  Procedures”). 
Comparison of the  most purified CPF from calf thymus  and 
HeLa cell nuclear  extracts showed that  proteins of similar 
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TABLE I1
Purification of CPF from HeLa nuclear extract 
CPF was purified  from 500 g of HeLa cells, as described under  “Experimental Procedures.” The purification 
and recovery are  relative  to  the  nuclear  extract.  Protein  concentrations were determined as described for the calf 
thymus purification. 
Fraction  Protein  Activity  Specific  activity  Purification Recovery 
w units X units X IO-’/lmg -fold % 
Extract 860 365 0.42 1 100 
DEAE-Sepharose 250 88.2  0.35  0.8  24 
Blue-Sepharose 18.4  43.7  2.4  5.7 12 
Heparin-Sepharose 1.6 10.0  6.3  15.0  2.7 
Mono Q 0.25  6.1  24.4  58.1  1.7 
Poly(A)-Sepharose -0.03  7.0 -230 -548 1.9 
A IP 19 20  21 22 23  24 25 26  27  28 29 30 31 32 A,,  , 1 
M -19 19  20  21  22  23 24 25,26 27 28 29 30  31  32 M 
201 ’=* 1 
97.4 
116 
66 
45 
29 
FIG. 3. Sedimentation of CPF in a glycerol gradient. Glyc- 
erol  gradient  centrifugation was  performed as described under  “Ex- 
perimental Procedures.” A, in  the  activity assay, 0.5 pl of the loaded 
sample (IP) and 2 pl of each  gradient  fraction were used. The  gradient 
fractions  are  indicated at   the top. B,  SDS gel electrophoresis of the 
glycerol gradient  fractions. 15 pl of the  input  material ( I P )  and 25 pl 
of each  gradient  fraction were precipitated with trichloroacetic  acid 
and analyzed on two 9% SDS polyacrylamide gels. The molecular 
masses of the  marker  proteins (M) in  kilodaltons  are  indicated on 
the left. 
molecular weights were purified from either source and  that 
the ratio of the four polypeptides to each other was compa- 
rable in both preparations (Fig. 2). For  the following experi- 
ments, we used a poly(A)-Sepharose fraction purified from 
calf thymus  extract if not indicated otherwise. 
CPF Is a Complex of Four Polypeptides-Upon centrifuga- 
tion through glycerol gradients,  all  four polypeptides cosedi- 
mented with CPF activity  in  a single peak (Fig. 3). Only the 
73-kDa protein was partially separated from CPF activity. 
The protein content of the complex formed between CPF 
and  the  substrate RNA was consistent with the  sedimentation 
data. CPF was run on a native polyacrylamide gel after 
incubation with or without radiolabeled L3pre RNA. The 
complex formed with RNA was located by autoradiography. 
Elution of the proteins out of this complex into a second 
dimension SDS-polyacrylamide gel resulted in  the  pattern of 
0 5 IO I5 20 2 5  30 35 4 0  
fraction number 
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FIG. 4. Sedimentation Constant of CPF. The sedimentation 
constant of CPF was determined with  a  poly(A)-Sepharose fraction 
that had been  purified in  the  absence of detergent  (see  text).  Sedi- 
mentation through a glycerol gradient was performed as described 
under  “Experimental Procedures.” The following proteins were ap- 
plied to parallel gradients  in  painvise combinations: RNase A (2 S), 
chymotrypsinogen (2.5 S), ovalbumin (3.5 S), BSA (4.5 S), aldolase 
(7.35 S), yeast alcohol  dehydrogenase (7.6 S), catalase (11.3 S), and 
thyroglobulin (19.3 S). The  marker  proteins were located by their UV 
absorbance  and  CPF by activity assays. A, sedimentation profile of 
CPF.  The  positions of some of the  marker  proteins  are indicated with 
their  sedimentation  constants. B, data of all  proteins were replotted. 
The position of CPF is  indicated by the arrow. 
the four proteins  (data  not shown). The same  protein pattern 
was observed in the second dimension  analysis of the corre- 
sponding gel region in the absence of substrate RNA. Most 
likely, the  short RNA molecule did not significantly influence 
the migration behavior of the protein complex to which it was 
bound. 
For determination of the sedimentation coefficient of CPF, 
another glycerol gradient  centrifugation was performed with 
CPF  that had  been purified in  the absence of detergent. In 
addition, this  preparation had been performed in the presence 
of protease inhibitors  and in the absence of  MgC12 (see above). 
The poly(A)-Sepharose  fraction of this preparation was about 
3-fold less pure  than  the corresponding standard preparation. 
Comparison to  marker  proteins resulted in a  sedimentation 
coefficient of 11.5 S (Fig. 4). 
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The  same  fraction was  analyzed by gel filtration  chroma- 
tography on a Superose 6 column. On this column, CPF 
behaved  slightly  heterogeneously (Fig. 5). The  Stokes  radius 
as determined by comparisonoto  standard  proteins (Siegel and 
Monty, 1966)  was near 100 A. From  the  sedimentation coef- 
ficient, the Stokes radius and an assumed partial specific 
volume of 0.73 mg/ml,  a native molecular mass of approxi- 
mately 500 kDa was  calculated  (Siegel and  Monty, 1966). The 
sum of the molecular  weights of the  four  polypeptides  deter- 
mined by gel electrophoresis is 360,000. In  the glycerol gra- 
dient,  as well as  in  the gel filtration of Fig. 5, an  additional 
protein with a molecular mass of 140 kDa  comigrated  with 
CPF, which was not observed in other preparations. The 
presence of this  protein may explain  the  discrepancy between 
the  native molecular weight and  the  sum of the  denatured 
molecular  weights of the  standard  CPF  preparation. 
For  the  detection of disulfide bonds involved in  the  inter- 
action of the four  polypeptides, an  aliquot of CPF was precip- 
itated with trichloroacetic acid and  resuspended  in gel-loading 
buffer lacking  2-mercaptoethanol. Half of this  sample  then 
received 5% 2-mercaptoethanol,  and  both  aliquots were heat- 
denatured  and analyzed on  an  SDS gel. The  30-kDa polypep- 
tide was visible only in  the  sample boiled in  the  presence of 
the reducing agent (Fig. 6). This suggests that  the 30-kDa 
polypeptide  may be bound via  disulfide bonds to  one of the 
other  CPF  subunits,  although  none of them  changed  in size 
under  nonreducing  conditions. 
A 
10 20 30 4 0  5 0  6 0  
fraction number 
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Stokes Radius (A) 
FIG. 5. Determination  of the Stokes radius by gel filtration. 
The detergent-free fraction was concentrated to approximately 0.3 
mg/ml in a Centricon 30 device (Amicon)  and 200 p1 of the  concen- 
trate were applied to a Superose 6 FPLC column (1 X 30  cm, 
Pharmacia)  that was equilibrated in buffer  A plus 100 mM KC1. The 
column was developed with the  same buffer, and  fraction of 300 ~l 
were collected. Marker proteins and their Stokes radii were c c o -  
chrome c (la.0  A),  chymotrypinogen (20.9 A), pvalbumin (30.5 A), 
BSA (35.5 A), aldolase- (48.1 A), catalase (52.2 A), ferritin (61.0 A), 
and thyroglobulin (85 A). The void volume of the  column was deter- 
mined  with  blue dextran. A ,  elution profile of CPF.  The void volume 
and  the  positions of some marker  proteins  together  with  their  radii 
are indicated  with arrowheads. R, determination of the  Stokes  radius 
of CPF according to Siegel and  Monty (1966). The position of CPF 
is indicated. 
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FIG. 6. SDS gel electrophoresis of CPF under  reducing  and 
nonreducing conditions. A poly(A)-Sepharose  fraction (-500 units 
of CPF activity) was precipitated  with  trichloroacetic acid and resus- 
pended  in loading  buffer lacking  2-mercaptoethanol.  Prior  to loading, 
one-half of the  sample was heat-denatured  in  the presence (lane I ), 
and  the  other half in  the absence, of 5% 2-mercaptoethanol (lane 2). 
The loaded samples were separated by several lanes  to avoid  diffusion 
of the reducing agent  through  the gel. The  marker  proteins were also 
loaded in the presence or absence of 5% 2-mercaptoethanol. The 
molecular masses of the  marker  proteins  in  kilodaltons  are indicated. 
Arrowheads mark the positions of the 160-, loo-, 73-, and 30-kDa 
polypeptides. M, marker  proteins. 
CPF Is Not a snRNP-Previous  experiments  (Christofori 
and Keller,  1988) had  indicated  that  the  U11  snRNP  might 
play a role in  CPF activity. Partially purified CPF was ana- 
lyzed by CsCl buoyant density centrifugation as described 
under  “Experimental Procedures.” CPF  activity was found  in 
fractions 1-8 at a density of 1.32-1.40 g/cm3 (Fig. 7A), with 
the  peak of activity  in  fraction 1 (1.32 mg/cm’). Total  protein 
showed a very similar  distribution (Fig. 7B).  U11 RNA had a 
broad  distribution  from  fraction 1 to  fraction 14 with  peaks 
in  fraction 2 (1.34 mg/cm3) and  fraction 8 (1.40 mg/cm3) (Fig. 
7C). snRNPs generally  show a heterogenous distribution  in 
Mono Q FPLC chromatography.3 Specifically, U11 snRNP 
particles eluting at low salt concentrations from Mono Q 
appeared as more slowly migrating complexes in a native 
polyacrylamide gel, compared with the  U11  snRNPs  eluted  at 
higher salt  concentrations  (data  not shown). Therefore, CsCl 
density  centrifugation was repeated  with a particular Mono 
Q fraction  that  had been eluted a t  a  higher salt  concentration 
and  contained  U11  snRNP,  as well as  CPF activity. In  this 
gradient, CPF again  banded at the  density of a protein (1.31 
mg/cm3),  whereas U11  snRNA was mainly  found at a snRNP- 
specific density (1.40-1.44 mg/cm3) (data  not  shown).  These 
results  thus clearly  show that  CPF  has  the  density of a  protein 
in CsCl buoyant  density  gradients, whereas the U11 snRNP 
has a heterogeneous density  distribution.  The majority of U11 
does not  cofractionate  with  CPF  in  this  type of separation. 
The removal of U11  RNA  in  the course of CPF purification 
was quantitated by northern  blot  analysis  (Table 111). A 1,700- 
fold reduction of U11  snRNA relative to  CPF was obtained. 
The most efficient separation of U11 RNA from CPF was 
‘ S. Bienroth, A., Kramer,  and W. Keller,  unpublished  observation. 
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FIG. 7. CsCl buoyant density centrifugation of CPF. CsCl 
gradients were performed as described under  “Experimental  Proce- 
dures.” The CsCl gradients were analyzed for the distribution of CPF 
activity, proteins, and U11 snRNA. A, CPF activity is indicated by 
filled circles. Open circles show the density of the fractions as deter- 
mined by weighing of 100-pl aliquots. E,  centrifugation of a protein 
mixture (Mono Q fraction; see “Experimental Procedures”). The UV 
absorbance is indicated by triangles, and  the density, by open circles. 
The same protein distribution was obtained  in a gradient that con- 
tained pure BSA (not shown). C, distribution of U11 RNA in the 
gradient. U11 RNA was measured by Northern  blotting (see “Exper- 
imental Procedures”) and scanning densitometry. Boxes indicate U11 
RNA, and open circles, the density of the fractions. 
TABLE I11 
Separation of U l l  RNA from CPF 
The concentration of U11 RNA was determined by Northern blot 
analysis in the various steps of the calf thymus CPF purification (see 
“Experimental Procedures”). 
Fraction U11 RNA U11 RNA/CPF activity 
Extract 
DEAE-Sepharose 
AmSO, pellet 
Blue-Sepharose 
Heparin-Sepharose 
Mono Q 
Spermine-agarose 
Polv(A)-SeDharose 
pmoles 
33,600 
10,420 
11,890 
1,260 
153 
45.5 
26.4 
0.375 
pmoles f units X 
8.5 
9.9 
2.2 
0.44 
0.16 
0.25 
0.005 
TABLE IV 
Affinity Chromatography of CPF with monoclonal antibodies  directed 
against the  trimethylguanosine cap of snRNAs 
An aliquot of a spermine-agarose fraction of calf thymus CPF was 
loaded on an anti-m3G affinity column as described under “Experi- 
mental Procedures.” 
Fraction CPF Recovery of U1l RNA Recovery of 
units % f m l  % 
activity CPF U11 RNA 
Input 1600 8000 
Unbound 880 55 660 8.3 
Bound 3.9 0.2 4000 50 
observed upon poly(A)-Sepharose chromatography, where 
98% of U11  RNA did not bind. The poly(A)-Sepharose frac- 
tion was also tested for the presence of other  snRNAs by 3’ 
end-labeling with pCp and RNA ligase (Kriimer, 1987). In 
addition to U11 RNA, comparable amounts of U1, U2, and 
U5 RNA  were found (data  not shown). 
CPF was analyzed by Western blotting with antibodies 
against common snRNP proteins (Luhrmann, 1988). The 
monoclonal antibody Y12 (Lerner et al., 1981), directed 
against the Sm epitope of snRNP proteins, and  the mono- 
clonal antibody H57 against the BB‘ proteins4 did not  detect 
any of the common snRNP proteins  (data  not shown). Since 
the sample contained small amounts of U RNAs (see above), 
snRNP proteins were probably present  in  concentrations  too 
low to be detectable by this method. However, the results rule 
out the presence of substantial quantities of an unknown 
snRNP whose RNA escaped detection of  3‘ end-labeling. 
A spermine-agarose CPF fraction was applied to  an affinity 
column that carried monoclonal antibodies directed against 
the trimethylguanosine cap  structure of snRNAs (anti-m3G 
affinity column). Recovery of CPF activity was 55% in  the 
flow-through and 0.24% in  the eluate. In contrast, most of 
the U11 RNA bound to  the affinity matrix. Only 8% of the 
initial  amount of U11 RNA did not  bind  (Table IV). Appli- 
cation of the poly(A)-Sepharose pool to  the anti-msG affinity 
column resulted in  a similar separation of CPF activity from 
U11  RNA (data  not shown). 
The poly(A)-Sepharose pool used in  the experiment shown 
in Fig. 8 (see below) contained 5 fmol of U11 RNA/pl, as 
determined by quantitative  Northern blot analysis. However, 
1 pl  of this  CPF fraction bound 100 fmol of labeled substrate 
RNA in  a gel shift assay. U11, therefore, cannot be responsible 
for binding of CPF  to  the  substrate RNA. The concentration 
of the 160-kDa protein  in the same fraction was estimated by 
comparison to a BSA standard on an SDS-polyacrylamide gel 
and amounted to -60 fmol/pl. This  protein is thus sufficiently 
abundant  to  account for RNA binding. 
Based on these  data, we conclude that U11 snRNP  is  not 
related to CPF. 
Specificity of Purified CPF for  the AA UAAA Sequence-An 
RNA substrate  (L3pre)  containing the AAUAAA signal was 
polyadenylated by poly(A) polymerase that was comple- 
mented with the poly(A)-Sepharose fraction of CPF. A single 
U to G conversion in  the recognition signal (L3preA) abol- 
ished polyadenylation (not shown). Polyadenylation of la- 
beled L3pre RNA  was almost completely competed by a 5-  
fold excess of unlabeled L3pre RNA but was not affected at 
all by the addition of a 10-fold excess of unlabeled L3preA 
substrate (Fig. 8A).  
CPF  in  the absence of any  other factor binds to  an RNA 
containing the AAUAAA signal (Gilmartin  and Nevins, 
1989).’ Incubation of CPF with L3pre and analysis of the 
R. Luhrmann, personal communication. 
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FIG. 8. CPF-dependent polyadenylation and binding of CPF 
to the  substrate RNA are dependent  on the AAUAAA signal. 
A, CPF (9 units of a  poly(A)-Sepharose pool) was incubated under 
polyadenylation  conditions  with 100 fmol of labeled L3pre RNA and 
different concentrations of nonlabeled competitor RNA. The reac- 
tions were analyzed on  a denaturing  12% polyacrylamide gel. Lane 1, 
minus C P F  lane 2, minus competitor; lanes 3-7, 100-1000 fmol of 
L3pre; lanes 8-12,100-1000 fmol of L3preA. The  amount of compet- 
itor RNA in each reaction is indicated at  the top of the panel. B,  CPF 
(9 units) was incubated  under complex formation  conditions  with 100 
fmol of labeled L3pre in a 6 . 2 5 ~ 1  reaction in  the presence of wild- 
type  and  mutant competitor RNA. Lane I, minus competitor; lanes 
2-6, 100-1000 fmol of L3pre; lanes 7-11, 100-1000 fmol of LBpreA. 
Competitor RNA concentrations  are indicated a t  the top of the panel. 
reaction on a native polyacrylamide gel resulted in the ap- 
pearance of a specific, slowly migrating  band.  This gel shift 
activity coincided with the polyadenylation activity in all 
purification  steps examined. No  binding  was observed when 
the mutant substrate was used (not shown). The specific 
binding was competed by an  unlabeled wild-type RNA  but 
not by a 10-fold excess of the  mutant (Fig. 823). 
These  experiments  demonstrate  that  the  binding of purified 
CPF is specific for  the AAUAAA signal. Furthermore,  CPF 
alone is sufficient for specific binding to  the  substrate RNA. 
DISCUSSION 
We  have described the  purification of CPF  as a complex of 
four polypeptides of 160, 100, 73, and 30 kDa. Purification 
from calf thymus homogenate and from HeLa cell nuclear 
extract gave essentially  the  same  protein  pattern.  The four 
proteins were present  in  approximately equimolar amounts, 
and their ratios and molecular weights did not change in 
response to the presence or absence of protease inhibitors 
during the purification. Sedimentation, gel filtration, and 
native gel electrophoresis demonstrated the formation of a 
tight complex  between the four proteins.  The  native molecular 
weight of the complex  was  roughly consistent  with  the  sum 
of the  denatured molecular  weights of its  components. Finally, 
the patterns of tryptic fragments of the four polypeptides 
showed no obvious similarities  (data  not  shown).  Taken  to- 
gether,  these  results uggest that  all  four  polypeptides  may  be 
genuine  subunits of CPF  and  that  none of the polypeptides is 
a proteolytic degradation product of any of the others. A 
partial separation of the 73-kDa polypeptide from CPF in 
glycerol sedimentation indicates that this protein is less 
tightly held in  the complex than  the  others.  Whether  it  is 
dispensable for CPF activity  remains  to be  shown. 
In  the  sedimentation  and gel filtration of CPF purified in 
the  presence of protease  inhibitors, an  additional polypeptide 
of 140 kDa  comigrated  with  the activity. However, all of the 
smaller polypeptides  were also  present  in  the  same  amount  as 
in  other  preparations.  Therefore,  it  appears  that  the smaller 
polypeptides are not degradation products of the 140-kDa 
protein.  The  latter  is  thus  not  an  essential  subunit of CPF. 
The  involvement of snRNPs  in  mRNA 3' end  formation 
has been  suggested  by  several lines of evidence  (see above). 
Specifically, the observation that the AAUAAA sequence 
could  be immunoprecipitated  from 3'-processing reactions by 
anti-Sm  antibodies  and by anti-trimethylguanosine  antibod- 
ies (Hashimoto  and  Steitz, 1986; Stefan0  and Adams, 1988; 
Moore et al., 1988) indicated  the association of a snRNP  with 
the AAUAAA sequence. Furthermore, in a partial purification 
of CPF,  the U11 snRNP appeared associated with  CPF activ- 
ity  (Christofori  and Keller,  1988). However, in  the purification 
reported  here a  1,700-fold reduction of the  ratio of U11 RNA 
to  CPF was  observed.  By Western  blot  analysis we also did 
not  detect  any  snRNP-specific  proteins in  purified CPF frac- 
tions. CPF did not bind to antibodies directed against the 
trimethylguanosine  cap  common  to  most  U-type  snRNAs.  In 
addition,  CPF  had  the  density of a protein  in CsCl buoyant 
density centrifugation. An earlier report that CPF has the 
density of a snRNP (Christofori  and Keller,  1988) could not 
be  confirmed.  Finally, the  amount of U11 RNA (or  any  other 
RNA)  in  purified  CPF was not sufficient to  account for the 
amount of substrate  RNA bound. In  contrast,  the  CPF poly- 
peptide  subunits were present  in  the  appropriate  quantities. 
Thus we conclude, in  agreement  with  other  reports  (Takagaki 
et al., 1989; Bardwell et al., 1991), that  CPF is not a snRNP. 
We  have observed that partially purified CPF  fractions could 
be immunoprecipitated  after UV cross-linking to L3pre  RNA 
with  anti-Sm  and  anti-BB'  antibody.  Thus  it  is possible that 
CPF  has a propensity to bind  snRNPs specifically or nonspe- 
cifically. Since  none of the  other processing factors  has so far 
shown  any  indication of containing  an  RNA  component, 3' 
end formation of polyadenylated mRNA may be the only 
major RNA-processing event  that proceeds without  the  in- 
volvement of a snRNP. However, it  remains possible that a 
snRNP  is involved in  the cleavage reaction. 
CPF  and poly(A)  polymerase, both purified to  near homo- 
geneity,  were sufficient  to  reconstitute AAUAAA-dependent 
polyadenylation. This  confirms  earlier  results obtained  with 
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partially purified components (see above). It has been dem- 
onstrated before (Gilmartin and Nevins, 1989; Bardwell et al., 
1991); and confirmed in this work, that CPF binds to 
AAUAAA. UV cross-linking studies identified two proteins of 
160 and 30 kDa as AAUAAA-specific RNA-binding compo- 
nents (Moore et al., 1988; Gilmartin and Nevins, 1991).* These 
two polypeptides are very likely to be the largest and smallest 
subunits of CPF. In a partially purified CPF fraction, a 170- 
kDa  protein that specifically cross-linked to  an AAUAAA- 
containing RNA  was  recognized by human SLE serum of the 
Sm serotype (Gilmartin and Nevins, 1991). However, in a 
Western blot analysis with monoclonal antibodies directed 
against the Sm epitope, we have not found a reaction with 
any of the polypeptides in  CPF. Possibly, the systemic lupus 
erythematosus serum contained .additional antibodies. The 
same systemic lupus erythematosus serum resulted in the 
coimmunoprecipitation of five polypeptides of 170,  130, 100, 
74, and 42 kDa (Gilmartin and Nevins, 1991). By size, three 
of these polypeptides might correspond to  the purified CPF 
subunits. Resolution of the four subunits  and  reconstitution 
of CPF are required to establish the roles of each of the 
subunits  in the recognition of  AAUAAA and  the interaction 
with other processing factors. 
The recognition of the AAUAAA sequence by CPF implies 
that  this factor already acts  in  the  first  step of the 3' end- 
processing reaction, the endonucleolytic cleavage. Previous 
studies showed that partially purified CPF is required for this 
cleavage reaction in the presence of additional cleavage factors 
(Christofori and Keller, 1988, Gilmartin et al., 1988; Gilmartin 
and Nevins, 1989; Takagaki et al., 1989; Takagaki et al., 1990). 
We have purified CPF based on its ability to reconstitute 
specific polyadenylation. However, additional experiments 
have shown that  this  CPF preparation also supports cleavage? 
It is intriguing that  CPF  is  an oligomeric complex with a 
high molecular weight. Poly(A) polymerase in  contrast is a 
simple enzyme consisting of a single polypeptide (Wahle, 
1991). This difference in complexity probably reflects the fact 
that during 3' processing CPF has to interact with the RNA 
substrate  but also with poly(A) polymerase and  the cleavage 
factors via protein-protein contacts. The elucidation of these 
multiple interactions will  be the subject of future studies. 
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